|
Re: Buyout?......
|
2
|
Resverlogix Corp.
|
Jun 02, 2019 08:07PM
|
|
Vaccinex
|
2
|
BIOASIS TECHNOLOGIES INC
|
Sep 03, 2018 08:51AM
|
|
Re: Morocco compared to Saudi
|
2
|
Resverlogix Corp.
|
Nov 03, 2021 06:59AM
|
|
Re: Drugmakers, scientists begin the hunt for long COVID treatments
|
2
|
Resverlogix Corp.
|
Mar 28, 2022 08:48AM
|
|
Re: "we are in now in the hands of the PI's running the trials"
|
2
|
Resverlogix Corp.
|
Oct 21, 2021 06:21PM
|
|
Re: What if
|
2
|
Resverlogix Corp.
|
Mar 07, 2019 06:26AM
|
|
Re: Hoping we see something significant before June
|
2
|
Resverlogix Corp.
|
Feb 15, 2023 11:25AM
|
|
Zacks
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jul 09, 2021 03:54PM
|
|
Re: Gilead pays $21B for Immunomedics, a single cancer drug (newly approved) for metastic Triple Negative Breast Cancer
|
2
|
Zenith Epigenetics
|
Sep 21, 2020 09:19AM
|
|
Posters sued successfully
|
2
|
Resverlogix Corp.
|
Jan 16, 2020 01:19PM
|
|
Re: RVX LEVEL II
|
2
|
Resverlogix Corp.
|
Aug 14, 2020 02:07PM
|
|
google
|
2
|
Zenith Epigenetics
|
Sep 21, 2020 09:24AM
|
|
Re: Patent Applications in U.S. and Europe
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jun 25, 2019 05:49AM
|
|
Re: Shrinking MACE event rate
|
2
|
Resverlogix Corp.
|
Jan 20, 2019 06:46AM
|
|
Re: Resverlogix presenting at Vascular Discovery 2019 next week
|
2
|
Resverlogix Corp.
|
May 11, 2019 09:48AM
|
|
Re: Short interest has been updated, can someone check the numbers....
|
2
|
Resverlogix Corp.
|
Jun 21, 2019 02:33PM
|
|
Re: HDL from an Alzheimer's disease perspective
|
2
|
Resverlogix Corp.
|
Jun 27, 2019 12:09PM
|
|
Re: Biotech Showcase, Jan 13-15
|
2
|
Resverlogix Corp.
|
Jan 08, 2020 02:18PM
|
|
Re: What's the deal with Zenith?
|
2
|
Zenith Epigenetics
|
Jun 22, 2023 03:30PM
|
|
Re: Vaccinex
|
2
|
BIOASIS TECHNOLOGIES INC
|
Sep 03, 2018 09:51AM
|
